{"status": "ok", "totalResults": 62, "articles": [{"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ET Now", "title": "'Buy pharma as a bucket, be stock-specific in auto sector'", "description": "\u201cRemain bullish on some of the consumption-related stocks which have been beaten down.\u201d", "url": "https://economictimes.indiatimes.com/markets/expert-view/buy-pharma-as-a-bucket-be-stock-specific-in-auto-sudip-bandyopadhyay-inditrade-capital/articleshow/65729844.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65729851,width-1070,height-580,imgsize-24478,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-08T06:14:30Z", "content": "The market is not crashing anytime soon. However, it is not going to move up sharply in a hurry either, Sudip Bandyopadhyay, Group Chairman, Inditrade Capital, tells ET Now. Edited excerpts: Do you believe that we can hold our head above the 10,600 mark? What\u2026 [+5456 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "PTI", "title": "Markets stage relief rally on value-buying", "description": "\u200b\u200bThe session was marked by high volatility and stock-specific action.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/markets-stage-relief-rally-on-value-buying-ril-leads-recovery/articleshow/65714921.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65714915,width-1070,height-580,imgsize-155561,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-07T04:20:06Z", "content": "MUMBAI: Markets staged a strong comeback on Thursday after six straight sessions of losses as investors accumulated recently hammered healthcare, energy and power stocks even as the rupee breached the 72 level for the first time. The BSE Sensex rebounded 224.\u2026 [+333 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "D-Street Buzz: Aurobindo Pharma, Sun Pharma most active; Motherson Sumi gains 4% on bonus issue", "description": "Metal index extend its gains in the afternoon trade, Coal India, JSW Steel, Vedanta, Tata Steel and Hindalco are among major metal gainers.", "url": "https://www.moneycontrol.com/news/business/markets/d-street-buzz-aurobindo-pharma-sun-pharma-most-active-motherson-sumi-gains-4-on-bonus-issue-2928541.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/07/indian_markets-770x433.jpg", "publishedAt": "2018-09-07T09:11:30Z", "content": "The Indian benchmark indices are witnessing rangebound session on Friday with the Nifty50 trading at 11,573, up 36 points, while the Sensex is trading higher by 81 points at 38,324. Reliance Industries, M&amp;M, ICICI Bank, HUL and Tata Motors are the positiv\u2026 [+1149 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "D-Street Buzz: Nifty pharma underperforms as Sun Pharma down 4%; Infosys up 1%", "description": "Nifty auto gained nearly 1 percent led by Bajaj Auto and TVS Motor up over 3 percent, followed by Apollo Tyres, Ashok Leyland, Exide, M&M and Hero Motocorp.", "url": "https://www.moneycontrol.com/news/business/markets/d-street-buzz-nifty-pharma-underperforms-as-sun-pharma-down-4-infosys-up-1-2927541.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/04/RTR2PMUA-770x433.jpg", "publishedAt": "2018-09-07T04:43:29Z", "content": "The Indian benchmark indices are trading lower on Friday morning with the Nifty50 trading at 11,518, down 18 points, while the Sensex is trading lower by 67 points at 38,175. Nifty pharma is down over 1 percent led by Sun Pharma down 4 percent on buzz of obse\u2026 [+1374 chars]"}, {"source": {"id": null, "name": "Indianexpress.com"}, "author": "PTI", "title": "Rupee edges higher by 4 paise against US dollar; Sensex, Nifty retract in early trade", "description": "The BSE benchmark Sensex drifted lower by nearly 166 points and the NSE Nifty slipped below the 11,500-level in the opening session Friday due to intense selling mainly in banking, power and healthcare shares amid weak Asian cues.", "url": "https://indianexpress.com/article/business/market/rupee-value-us-dollar-sensex-nifty-5344370/", "urlToImage": "https://images.indianexpress.com/2018/05/rupee-money-currency-759.jpg?w=759", "publishedAt": "2018-09-07T05:34:20Z", "content": "By: PTI | Mumbai | Published: September 7, 2018 11:04:20 am The rupee Thursday plunged to new record low of 72.11 a dollar in intra-day trade before closing at 71.99, showing a steep 24 paise fall. The rupee Friday opened on a positive note and was trading ma\u2026 [+1996 chars]"}, {"source": {"id": null, "name": "Indianexpress.com"}, "author": "ENS Economic Bureau", "title": "Rupee nears 72 level on panic rush among investors for dollars", "description": "Dealers said the central bank sold $24 billion during the span when the rupee fell from 65 to the dollar to 69 while it has sold just about $5 billion when it moved from 70 to 72.", "url": "https://indianexpress.com/article/business/market/rupee-nears-72-level-on-panic-rush-among-investors-for-dollars-5344042/", "urlToImage": "https://images.indianexpress.com/2018/03/rupee-7591.jpg?w=759", "publishedAt": "2018-09-06T22:34:21Z", "content": "The RBI then intervened in a mild way and the rupee recouped partially and closed at 71.99 against the dollar. (Representational Image) The rupee on Thursday fell below the 72 mark in intra-day trading for the first time and closed 23 paise down at 71.99 agai\u2026 [+3098 chars]"}, {"source": {"id": "the-hindu", "name": "The Hindu"}, "author": "Special Correspondent", "title": "Indices gain after six days of decline", "description": "Even as the rupee touched a new low on Thursday by falling below the 72-mark against the U.S. dollar for the first time ever, the benchmark equity ind", "url": "https://www.thehindu.com/business/indices-gain-after-six-days-of-decline/article24885253.ece", "urlToImage": "https://www.thehindu.com/static/theme/default/base/img/og-image.jpg", "publishedAt": "2018-09-06T16:45:45Z", "content": "Even as the rupee touched a new low on Thursday by falling below the 72-mark against the U.S. dollar for the first time ever, the benchmark equity indices gained ground after six consecutive days of losses. The 30-share Sensex gained 224.50 points, or 0.59%, \u2026 [+1405 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Sun Pharma falls 5% on report of co getting 6 observations by US FDA for Halol unit", "description": "The observations include aspects such as lack of appropriate test measures for lab controls along with some procedural issues too.", "url": "https://www.moneycontrol.com/news/business/markets/sun-pharma-falls-5-on-report-of-co-getting-6-observations-by-us-fda-for-halol-unit-2927441.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/04/RTR4USB5-770x433.jpg", "publishedAt": "2018-09-07T04:07:01Z", "content": "Shares of Sun Pharmaceutical fell over 5 percent on Friday morning on buzz of observations being issued by the US drug regulator for its Halol plant. The stock touched an intraday high of Rs 658.00 and an intraday low of Rs 640.95. According to reports on CNB\u2026 [+763 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Bulls trying to take over D-Street! But, over 60 stocks hit a fresh 52-week low in September", "description": "The S&P BSE Sensex managed to reclaim 38,000 marks in the week gone by but there are over 60 stocks which hit a fresh 52-weeks low in the S&P BSE Small-cap index and just 26 stocks hit a 52-week high is a sign of caution.", "url": "https://www.moneycontrol.com/news/business/stocks/bulls-trying-to-take-over-d-st-but-over-60-stocks-hit-a-fresh-52-week-low-in-september-2931521.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/07/Sensex_Nifty_BSE_NSE_Stocks_markets_BSE_traders-770x433.jpg", "publishedAt": "2018-09-08T04:54:44Z", "content": "Indian markets which were hitting record highs last month came under pressure in the first week of September losing nearly a percent. The S&amp;P BSE Sensex lost 256 points while the Nifty50 ended 0.78 percent lower for the week ended 7 September. Both Sensex\u2026 [+2724 chars]"}, {"source": {"id": null, "name": "Firstpost.com"}, "author": "Press Trust of India", "title": "Sensex drifts lower by 166 points to 38,077, Nifty slips below 11,500-level in early trade in line with Asian markets", "description": "Sensex dropped by 165.72 points, or 0.43 per cent, to 38,077.09 in opening trade as index major Sun Pharma, Yes Bank, SBI, ICICI Bank, NTPC, ONGC and Maruti Suzuki declined The post Sensex drifts lower by 166 points to 38,077, Nifty slips below 11,500-level i\u2026", "url": "https://www.firstpost.com/business/sensex-drifts-lower-by-166-points-to-38077-nifty-slips-below-11500-level-in-early-trade-in-line-with-asian-markets-5134291.html", "urlToImage": "https://res.cloudinary.com/firstpost/image/upload/q_auto,f_auto,fl_lossy/nw18-firstpost/2018/08/sensex-bse_01.jpg", "publishedAt": "2018-09-07T04:35:39Z", "content": "Mumbai: The BSE benchmark Sensex drifted lower by nearly 166 points and the NSE Nifty slipped below the 11,500-level in the opening session Friday due to intense selling mainly in banking, power and healthcare shares amid weak Asian cues. The BSE 30-share bar\u2026 [+1111 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Pharma weekly wrap: A busy week with Aurobindo#39;s US buyout and break-up of Singh brothers", "description": "The cheaper valuation of the acquisition target and Aurobindo#39;s past track record in integrating and turning around acquired companies made most analysts and investors give was thumbs-up to the deal", "url": "https://www.moneycontrol.com/news/business/companies/pharma-weekly-wrap-a-busy-week-with-aurobindos-us-buyout-and-break-up-of-singh-brothers-2932231.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/07/A4-770x433.jpg", "publishedAt": "2018-09-08T09:38:15Z", "content": "It was an action-packed week for pharma and healthcare. The biggest development of the week was India\u2019s second-largest drugmaker Aurobindo Pharma's acquisition of commercial operations and three manufacturing units from Sandoz, a Novartis generic division, in\u2026 [+2780 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "An evening walk down Dalal Street | Bulls drive Sensex almost 150 points higher, Nifty above 11,550", "description": "Index heavyweights led the gainers\u00e2\u0080\u0099 chart as the likes of Reliance Industries, ICICI Bank and Mahindra Mahindra pushed up benchmarks higher.", "url": "https://www.moneycontrol.com/news/business/markets/an-evening-walk-down-dalal-street-bulls-drive-sensex-almost-150-points-higher-nifty-above-11550-2929631.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/07/evening_walk_down_wall_street-1-770x433.jpg", "publishedAt": "2018-09-07T10:32:17Z", "content": "What a fantastic Friday it was for the bulls! A huge surge in the midcaps space along with automobiles, pharmaceuticals as well as energy names ensured that the market had a strong trading day. The Nifty managed to end well above 11,550-mark. The midcap index\u2026 [+2729 chars]"}, {"source": {"id": null, "name": "Moneycontrol.com"}, "author": null, "title": "Competition Commission approves Linde-Praxair deal", "description": "\"CCI India approves combination of Linde and Praxair, subject to compliance of certain modifications,\" the regulator said in a tweet Friday.", "url": "https://www.moneycontrol.com/news/india/competition-commission-approves-linde-praxair-deal-2930841.html", "urlToImage": "https://static-news.moneycontrol.com/static-mcnews/2018/08/a-black-reflective-rubber-stamp-stamping-a-white-surface-leaving-a-green-approved-sign-behind_vjxwvkk-x__F0006-770x433.png", "publishedAt": "2018-09-07T15:20:04Z", "content": "Fair trade regulator CCI has approved the merger of industrial gas firms Linde and Praxair, subject to certain conditions. The deal, announced in June 2017, is worth over $70 billion, according to reports. \"CCI India approves combination of Linde and Praxair,\u2026 [+1108 chars]"}, {"source": {"id": null, "name": "Thehindubusinessline.com"}, "author": "PT Jyothi Datta", "title": "Sun Pharma gets regulatory observations from USFDA", "description": "Company says it will respond to the six observations on its Halol facility in two weeks", "url": "https://www.thehindubusinessline.com/news/sun-pharma-gets-regulatory-observations-from-usfda/article24896555.ece", "urlToImage": "https://www.thehindubusinessline.com/news/py1j4q/article24896554.ece/ALTERNATES/LANDSCAPE_615/BL08SUNPHARMA", "publishedAt": "2018-09-07T16:46:45Z", "content": "Drugmaker Sun Pharma has got six regulatory observations on its Halol factory in Gujarat from the US Food and Drug Administration, the company said, adding that it would respond in two weeks. \u201cThe USFDA conducted a pre-approval inspection (PAI) of Sun Pharmac\u2026 [+2199 chars]"}, {"source": {"id": "the-hindu", "name": "The Hindu"}, "author": "Venkatesh Varadachari", "title": "Reading the rupee", "description": "What is the implication of a weakening rupee for the investment market?", "url": "https://www.thehindu.com/education/reading-the-rupee/article24901739.ece", "urlToImage": "https://www.thehindu.com/education/urgmam/article24901738.ece/ALTERNATES/LANDSCAPE_615/10EPBSMONEYMATTERSjpg", "publishedAt": "2018-09-08T08:55:49Z", "content": "For those of us using motor vehicles, the last few weeks have been painful. Petrol and diesel prices are inching higher and higher, and these days it costs a lot more to fill our fuel tanks. In this column, let us examine why this is happening. Along the way,\u2026 [+2695 chars]"}, {"source": {"id": null, "name": "Livemint.com"}, "author": "Nirav Vyas", "title": "Stock Market LIVE: Sensex falls 150 points; Sun Pharma shares down 5%", "description": "BSE Sensex falls over 150 points, while the Nifty 50 trades near 11,500. Here are the latest updates from the markets", "url": "https://www.livemint.com/Money/zoNuj6RnMQOfTvyfiqTKKN/Stock-Market-LIVE-Sensex-Nifty-set-to-open-higher-Infosys.html", "urlToImage": "https://www.livemint.com/rf/Image-621x414/LiveMint/Period2/2018/09/08/Photos/Home%20Page/bse1-kj1C--621x414@LiveMint.JPG", "publishedAt": "2018-09-07T03:34:10Z", "content": null}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ETMarkets.com", "title": "Buzzing stocks: YES Bank, Aurobindo Pharma, Sun Pharma, RIL", "description": "Sustained capital outflow amid weak Asian cues also dented sentiment.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/buzzing-stocks-yes-bank-aurobindo-pharma-sun-pharma-ril/articleshow/65715201.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65715224,width-1070,height-580,imgsize-133450,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-07T04:33:46Z", "content": "NEW DELHI: With over 1.30 crore shares changing hands, Jaiprakash Associates was leading among the most traded stocks on NSE in morning trade on Friday. It was followed by YES Bank (number of shares traded: 1.13 crore), Reliance Communications (1.09 crore) an\u2026 [+1567 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ETMarkets.com", "title": "Sun Pharma slips 4% on USFDA observations", "description": "Sun Pharma has reported a consolidated net profit of Rs 982.51 crore for the June quarter.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/sun-pharma-slips-4-on-usfda-observations/articleshow/65715221.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65715216,width-1070,height-580,imgsize-91114,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-07T04:50:17Z", "content": "NEW DELHI: Shares of Sun Pharmaceutical Industries weakened over 4 per cent on Friday after a media report stated that the USFDA issued six observations to the company\u2019s Halol plant for inspection in August. The scrip was 4.05 per cent down at Rs 649.25 at ar\u2026 [+640 chars]"}, {"source": {"id": "the-times-of-india", "name": "The Times of India"}, "author": "ETMarkets.com", "title": "Share market update: Aurobindo Pharma, Lupin lift pharma pack, but Sun Pharma weighs", "description": "The Nifty Pharma index was trading 0.31 per cent up at 10,616 around 01:45 pm.", "url": "https://economictimes.indiatimes.com/markets/stocks/news/share-market-update-aurobindo-pharma-lupin-lift-pharma-pack-but-sun-pharma-drag/articleshow/65718150.cms", "urlToImage": "https://img.etimg.com/thumb/msid-65718170,width-1070,height-580,imgsize-128415,overlay-etmarkets/photo.jpg", "publishedAt": "2018-09-07T08:12:43Z", "content": "NEW DELHI: Gains in shares of Aurobindo Pharma (up 5.99 per cent), Lupin (up 3.16 per cent), Dr. Reddy's Laboratories (up 1.99 per cent) and Cadila Healthcare (up 0.72 per cent) were keeping the Nifty Pharma index in the green in Friday's session. However, lo\u2026 [+1137 chars]"}, {"source": {"id": null, "name": "Firstpost.com"}, "author": "Press Trust of India", "title": "Sensex gains 224.50 points to close 38,242.81, Nifty ends above 11,500; RIL leads recovery", "description": "Sensex, Nifty staged a strong comeback on Thursday after six straight sessions of losses as investors accumulated recently hammered healthcare, energy and power stocks towards the fag-end even as the rupee breached the 72-level for the first time. The post Se\u2026", "url": "https://www.firstpost.com/business/sensex-gains-224-50-points-to-close-38242-81-nifty-ends-above-11500-ril-leads-recovery-5129361.html", "urlToImage": "https://res.cloudinary.com/firstpost/image/upload/q_auto,f_auto,fl_lossy/nw18-firstpost/2018/07/stock-trader2-Reuters_social1.jpg", "publishedAt": "2018-09-06T10:37:54Z", "content": "Mumbai: Markets staged a strong comeback on Thursday after six straight sessions of losses as investors accumulated recently hammered healthcare, energy and power stocks towards the fag-end even as the rupee breached the 72-level for the first time. The BSE S\u2026 [+1375 chars]"}]}